Man Group PLC Biomarin Pharmaceutical Inc Transaction History

Man Group PLC

$36 Billion
Q3 2024

A detailed history of Man Group PLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Man Group PLC holds 616,078 shares of BMRN stock, worth $40 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

616,078

Previous 130,408 372.42%

Holding current value

$40 Million

Previous $10.7 Million 303.35%

% of portfolio

0.12%

Previous 0.03%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$69.02 - $93.84 $33.5 Million - $45.6 Million	485,670 Added 372.42%	616,078 $43.3 Million
Q2 2024 Aug 14, 2024	BUY	$74.43 - $92.22 $3.38 Million - $4.18 Million	45,362 Added 53.34%	130,408 $10.7 Million
Q1 2024 May 15, 2024	BUY	$83.81 - $99.0 $1.74 Million - $2.05 Million	20,703 Added 32.18%	85,046 $7.43 Million
Q4 2023 Feb 14, 2024	SELL	$76.22 - $98.51 $2.21 Million - $2.86 Million	-29,049 Reduced 31.1%	64,343 $6.2 Million
Q3 2023 Nov 14, 2023	SELL	$85.07 - $94.48 $15.8 Million - $17.6 Million	-185,942 Reduced 66.57%	93,392 $8.26 Million
Q2 2023 Aug 14, 2023	SELL	$86.68 - $100.3 $39.1 Million - $45.3 Million	-451,312 Reduced 61.77%	279,334 $24.2 Million
Q1 2023 May 15, 2023	BUY	$87.74 - $117.27 $5.85 Million - $7.82 Million	66,677 Added 10.04%	730,646 $71 Million
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $9.34 Million - $12.5 Million	115,421 Added 21.04%	663,969 $68.7 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $31.6 Million - $37.2 Million	384,258 Added 233.89%	548,548 $46.5 Million
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $7.11 Million - $8.64 Million	99,513 Added 153.62%	164,290 $13.6 Million
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $4.81 Million - $6 Million	64,777 New	64,777 $5 Million
Q4 2021 Feb 14, 2022	SELL	$71.72 - $91.47 $771,994 - $984,583	-10,764 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $412,356 - $471,367	-5,515 Reduced 33.88%	10,764 $832,000
Q2 2021 Aug 16, 2021	SELL	$75.51 - $84.79 $3.59 Million - $4.03 Million	-47,504 Reduced 74.48%	16,279 $1.36 Million
Q1 2021 May 17, 2021	BUY	$74.73 - $90.69 $1.34 Million - $1.62 Million	17,868 Added 38.92%	63,783 $4.82 Million
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $47,632 - $59,171	656 Added 1.45%	45,915 $4.03 Million
Q3 2020 Nov 16, 2020	SELL	$71.87 - $131.03 $3.46 Million - $6.31 Million	-48,177 Reduced 51.56%	45,259 $3.44 Million
Q2 2020 Aug 14, 2020	BUY	$79.55 - $124.22 $5.16 Million - $8.05 Million	64,813 Added 226.44%	93,436 $11.5 Million
Q1 2020 May 15, 2020	SELL	$71.37 - $96.85 $976,127 - $1.32 Million	-13,677 Reduced 32.33%	28,623 $2.42 Million
Q4 2019 Feb 18, 2020	BUY	$64.27 - $86.37 $222,374 - $298,840	3,460 Added 8.91%	42,300 $3.58 Million
Q3 2019 Nov 14, 2019	BUY	$67.4 - $85.11 $102,582 - $129,537	1,522 Added 4.08%	38,840 $2.62 Million
Q2 2019 Aug 14, 2019	SELL	$80.35 - $93.9 $485,072 - $566,874	-6,037 Reduced 13.92%	37,318 $3.2 Million
Q1 2019 May 15, 2019	SELL	$84.2 - $98.62 $2.67 Million - $3.13 Million	-31,711 Reduced 42.24%	43,355 $3.85 Million
Q4 2018 Feb 14, 2019	SELL	$80.14 - $106.07 $1.13 Million - $1.5 Million	-14,116 Reduced 15.83%	75,066 $6.39 Million
Q3 2018 Nov 14, 2018	BUY	$93.92 - $105.72 $5.93 Million - $6.67 Million	63,109 Added 242.05%	89,182 $8.65 Million
Q2 2018 Aug 14, 2018	SELL	$76.01 - $99.03 $6.93 Million - $9.02 Million	-91,113 Reduced 77.75%	26,073 $2.46 Million
Q1 2018 May 15, 2018	BUY	$77.67 - $92.63 $9.1 Million - $10.9 Million	117,186 New	117,186 $9.5 Million

Others Institutions Holding BMRN

# of Institutions

638

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account